The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis

Jessica Maetz, Jessica Denning

Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Journal Issue: March

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jessica Maetz, Jessica Denning. The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis. Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The ageing cystic fibrosis patient
Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients
Year: 2018


Does this patient have cystic fibrosis? 
Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session
Year: 2017


A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021


Late presenting cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis: no longer just kids‘ stuff
Year: 2005

Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012


Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020
Year: 2021



Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019
Year: 2020



Cystic fibrosis patients: do they profit from altitiude residence?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006


Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

The surgical treatment of the lungs complication in the course of cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 323s
Year: 2003

Pneumothorax in cystic fibrosis: management and outcome
Source: Eur Respir J 2006; 28: Suppl. 50, 50s
Year: 2006

Treatment of advanced cystic fibrosis lung disease and end of life decisions
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Early renal involvement in children with cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018


Health-economic aspects of cystic fibrosis screening and therapy
Source: Eur Respir Monogr 2014; 64: 304-319
Year: 2014


Cystic fibrosis: prospects for therapy of some class 1 mutations
Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?
Year: 2007


Global impact of bronchiectasis and cystic fibrosis
Source: Breathe 2016; 12: 222-235
Year: 2016



How useful is the lung ultrasound in cystic fibrosis?
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016